Amway India Enters Ayurveda Segment With Nutrilite Range, Aims for Rs 100 Crore Sales
Amway India has announced its entry into the traditional Indian wellness segment by introducing nine Nutrilite Ayurveda products. Through this expansion, the direct selling enterprise is targeting Rs 100 crore in sales from the category across the next two years.
What Happened
Amway India has formally entered the Ayurveda market with a new range under its Nutrilite brand. The firm stated that the formulations rely on Ayurvedic botanicals obtained from organically cultivated farms. These products are being produced locally at the company’s manufacturing facility situated in Tamil Nadu.
As part of the initial phase of this market entry, Amway India has introduced three formulations: Kalamegha, Shigru (moringa), and Vrikshamla (garcinia). According to the company’s product specifications, Kalamegha is designed to support liver function, Shigru is targeted at assisting with the management of inflammation and fat deposition, and Vrikshamla is formulated to aid satiety and metabolism.
Key Highlights
- Product Rollout: A total of nine Nutrilite Ayurveda products have been planned, beginning with an initial launch of three formulations: Kalamegha, Shigru, and Vrikshamla.
- Sales Target: Amway India has set a revenue target of Rs 100 crore from this specific product segment within two years.
- Manufacturing and Sourcing: Ingredients are sourced from organic farms, while product manufacturing is managed at the company’s site in Tamil Nadu.
- Executive Commentary: Amway India Managing Director Rajneesh Chopra noted that rising consumer interest in preventive healthcare and Ayurveda is expected to support business growth in the category.
Why This Matters
The company is seeking to address consumer demands around wellness and traditional health solutions. Rajneesh Chopra pointed out that consumers are increasingly viewing Ayurveda as a regular wellness option while actively looking for transparency, consistency, and scientific validation. By combining its botanical research with domestic manufacturing and traditional formulations, Amway India aims to establish a foothold in the preventive health sector.
What to Watch Next
Following the first phase of three formulations, Amway India plans to expand its presence by rolling out the remaining products to complete the announced nine-item portfolio. The progress of the business toward its Rs 100 crore target over the two-year timeline will serve as a key marker for its performance in the Ayurveda sector.
Frequently Asked Questions
What revenue target has Amway set for its Ayurveda category?
Amway India aims to generate Rs 100 crore in sales from its Ayurveda product line over the next two years.
Which products were introduced in the first phase?
The initial phase includes three formulations: Kalamegha for liver function support, Shigru (moringa) for managing inflammation and fat deposition, and Vrikshamla (garcinia) for metabolism and satiety support.
Where are these products manufactured?
The company manufactures the Nutrilite Ayurveda range at its facility located in Tamil Nadu using botanicals from organically cultivated farms.
Source: Based on reporting by The Times of India.